|
|
Volumn 63, Issue 3, 2002, Pages 162-165
|
|
Somatuline Autogel: an extended release lanreotide formulation.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOPEPTIN;
ANTINEOPLASTIC AGENT;
CYCLOPEPTIDE;
DRUG DERIVATIVE;
GROWTH HORMONE;
OCTREOTIDE;
SOMATOMEDIN C;
SOMATOSTATIN;
ACROMEGALY;
ADULT;
CARCINOID;
CHEMISTRY;
DELAYED RELEASE FORMULATION;
FEMALE;
HUMAN;
INTRADERMAL DRUG ADMINISTRATION;
MALE;
METABOLISM;
MIDDLE AGED;
REVIEW;
RISK FACTOR;
SECRETION;
ACROMEGALY;
ADULT;
ANTINEOPLASTIC AGENTS;
CARCINOID TUMOR;
CHEMISTRY, PHARMACEUTICAL;
DELAYED-ACTION PREPARATIONS;
FEMALE;
GROWTH HORMONE;
HUMANS;
INJECTIONS, INTRADERMAL;
INSULIN-LIKE GROWTH FACTOR I;
MALE;
MIDDLE AGED;
OCTREOTIDE;
PEPTIDES, CYCLIC;
RISK FACTORS;
SOMATOSTATIN;
|
|
EID: 0036513129
PISSN: 14623935
EISSN: None
Source Type: Journal
DOI: 10.12968/hosp.2002.63.3.2062 Document Type: Review |
|
Times cited : (28)
|
|
References (15)
|
